عدسة مكبرة
بحث محمل

Steven Howard & Chris Abell 
Fragment-Based Drug Discovery 

الدعم
Adobe DRM
غلاف Steven Howard & Chris Abell: Fragment-Based Drug Discovery (ePUB)

Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique.


This book is written from a Chemist’s perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in novel drug discovery techniques.

€229.99
طرق الدفع

قائمة المحتويات

Different flavours of Fragments; Advances in SPR Technology; Applications of NMR in Fragment-Based Drug Discovery; Issues around Fragments as an Approach, including a Computational/in silico Perspectives on Fragment-Based Drug Discovery; Fragment-Based Drug Discovery of Kinase Inhibitors; Fragment-Based Discovery of Antibacterials; Strategies for Fragment-Based Lead Generation; Fragment-Based Approaches to Epigenetic Targets; Application of Fragment-Based Drug Discovery to GPCRs; Fragment-Based Drug Discovery applied to Protein-Protein Interactions; Probing Difficult Targets
لغة الإنجليزية ● شكل EPUB ● صفحات 314 ● ISBN 9781782625650 ● حجم الملف 5.9 MB ● محرر Steven Howard & Chris Abell ● الناشر Royal Society of Chemistry ● نشرت 2015 ● الإصدار 1 ● للتحميل 24 الشهور ● دقة EUR ● هوية شخصية 5495486 ● حماية النسخ Adobe DRM
يتطلب قارئ الكتاب الاليكتروني قادرة DRM

المزيد من الكتب الإلكترونية من نفس المؤلف (المؤلفين) / محرر

11٬401 كتب إلكترونية في هذه الفئة